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ABSTRACT: A lumbar epidural steroid injection is aimed at decreasing inflammation in the low
back and causing a residual decrease in low back and radicular pain. There is currently no
community standard regarding the amount of bed rest and activity following a lumbar epidural
steroid injection (LESI). The aim of this research was to determine if there is a relationship
between length of rest and self-rated pain relief, disability and side effects following interlaminar
LESIs in a given clinic population. A total of 110 subjects were recruited with an age range
between 23 and 85. Mean age of the control group was 50.9 and experimental group mean age
was 52.2. No statistical difference in pain relief, level of disability or side effects was found at
the two week follow up survey. This research has the potential to influence how patients are
cared for after a LESI and provide evidenced based care.
KEYWORDS: Lumbar epidural steroid injection, Length of rest, Pain relief, Activity
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BACKGROUND
Low back pain is the fifth most common reason for all physician visits in the United States
(U.S.). Approximately one quarter of U.S. adults reported having low back pain in the last year
and more than 85% of patients who present to primary care have low back pain that can not
reliably be attributed to a specific disease or spinal abnormality- nonspecific low back pain
(Chou et al., 2007). Since its introduction as a treatment option in 1952, lumbar epidural steroid
injections (LESI) have been conducted as one of the main treatment methods for low back and
radicular pain, also called sciatica, which is pain that radiates from the site of a pinched nerve in
the low back to the area of the body aligned with that nerve, such as the back of the leg or into
the foot (Lee, Moon, & Lee, 2009). For managing low back pain, LESIs are one of the most
commonly performed interventions in the U.S. (Manchikanti et al., 2011). It was found that
interlaminar LESIs were effective for axial low back pain in four-fifths of patients (Lee et al.,
2010).
LESI: What it is and how it works.
A LESI is a procedure in which the radiologist inserts a needle into the epidural space in the
lower back under fluoroscopic guidance and a steroid is delivered. At the study site, a steroid
solution (Celestone Soluspan) along with a local anesthetic (Lidocaine) are used. The steroid
decreases the inflammation within the lumbar and sacral nerves and may provide pain relief for a
period of time. Steroids inhibit the inflammatory response caused by chemical and mechanical
sources of pain. Inflammation is reduced by the corticosteroids which inhibit either the synthesis
or release of a number of pro-inflammatory mediators (Lee et al., 2010). Theoretically, LESIs
place a higher concentration of steroid at the site of pathologically indicated pain compared with
a systematic oral therapy approach which would likely also have more systematic side effects
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(Friedrich & Harrast, 2010). The pain relief is not immediate and it may take up to two weeks to
feel the full effects of the medication. The medication will not change the disc in any way but is
intended to reduce inflammation around the disc, reducing pain which can be very beneficial for
a patient during an acute episode of back and or leg pain.
Current aftercare practice
Patients undergoing a LESI at the Minnesota Diagnostic Center (MDC), imaging center for the
Noran Neurological Clinic (NNC), currently complete 15 minutes of flat rest on the fluoroscopy
table followed by 45 minutes of flat rest in the nursing area after the injection and are instructed
to rest for the remainder of the day. The patient stays on the fluoroscopy table at a slight angle
for 15 minutes to monitor that the Lidocaine has not gone into the subarachnoid space. If it has,
the table can be adjusted to a greater angle to ensure patient safety. The current practice at the
MDC requires patients to be in the clinic for at least two hours (including early arrival and bed
rest) and have someone to drive them home.
An examination of this protocol needed to be implemented in order to determine its
effectiveness because the MDC is currently the only clinic to practice one hour bed rest in the
Twin Cities. There are several clinics in the Twin Cities that perform LESIs and they each have
protocols following the injection. Phone interviews were conducted to technologists at six local
facilities and it was found that the majority of facilities practice rest after the LESI ranging from
15-30 minutes, with one facility requiring no bed rest. At these facilities, patients resume normal
activity following the LESI and a driver is usually required. When these facilities were contacted
to explain their rationale for current aftercare protocols, the determining factor was how the
patient was responding to the Lidocaine. If they were able to walk with no weakness, they were
able to go after their allotted time while some facilities required the radiologist to assess the

LESI Research Study

5

patient before leaving. All of the facilities have been following their current protocols for at least
five plus years or as long as they have been doing LESIs. There has been no published data
pertaining to an increase in side effects following shorter bed rest and the other local facilities
have not found an increase in adverse reactions or side effects with their required length of rest.
There is currently no community norm or standard of care in the radiology field for
aftercare of patients receiving LESIs. Since there is no published data pertaining to the area, this
study will begin to provide the baseline knowledge to the radiology field on the effect that rest
either has or does not have following LESIs. It will also allow facilities performing these
injections to base practice on current evidence rather than physician preferences and provide
patients with evidence based care, promoting best patient care. In the future, this evidence has
the potential to reduce health care cost and better utilize health care resources. The aim of this
research was to determine if there was a relationship between length of rest and self-rated pain
relief and Oswestry Disability Index (ODI) following interlaminar LESIs in a given clinic
population.
Research questions
There were two research questions for this study: 1. Is there a difference between a subjects self
reported pain and ODI before and two weeks post LESI after completing one hour of flat rest in
the clinic (15 minutes on the fluoroscopy table and 45 minutes in the nursing area) and resting
for the remainder of the day compared with completing 15 minutes of flat rest on the fluoroscopy
table and 15 minutes of flat rest in the nursing area and resuming activity as normal? 2. What
side effects (headache, facial flushing, increased low back pain, trouble sleeping, or sweating)
were experienced by the subject following the LESI? The purpose of this study was to evaluate if
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length of rest had an effect on a subject’s self-rated pain relief, disabilities related to back pain,
and side effects experienced following a LESI.
It was hypothesized that among patients receiving LESIs, those who completed 30
minutes of flat rest and resumed normal activity would have an equal amount of perceived
benefit (pain relief) from the LESI compared with those that did one hour of flat rest and rested
for the remainder of the day.
REVIEW OF LITERATURE
The research for this article was done with literature from 2000 to 2011 using CINAHL,
Medline, and PubMed. Keywords for the searches of the literature included “Pain,” “Lumbar,”
“Epidural,” “Steroid,” “Injection,” “Back,” “Activity,” “Bed rest,” “Benefits,” and
“Complications.” Literature related specifically to bed rest and activity recommended after any
type of LESI was non-existent. Studies that examined the effect length of bed rest had on the
prevention of a spinal headache following a cervical or lumbar puncture were found along with
the benefits, complications, and risks associated with LESIs. The final review of publications
were scholarly, peer-reviewed journal articles in English that specifically discussed the benefits
and complications of epidural steroid injections along with the effect activity has on cervical and
lumbar punctures.
Potential benefits
Epidural steroid injections are commonly administered to relieve pain and improve mobility
without surgery. LESIs are used to effectively treat lumbar spinal stenosis, herniated lumbar
intervertebral disc disease, and lumbar degenerative disc disease (Yoo et al., 2009). Benefits of
the epidural steroid injections include relief of radicular pain, improved quality of life, reduction
of analgesic consumption, improved maintenance of work status and elimination of the need for
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surgery in many patients. Acute lower back pain often starts with a traumatic event and many of
the injuries can heal over time (Snarr, 2007). However, the issue for most patients is controlling
the pain and maintaining function until healing can occur. Generally, up to three epidural steroid
injections per year are performed if clinically indicated but it is believed that their effectiveness
decrease over time.
Potential complications
Potential complications related to the procedure itself also need to be considered when planning
an epidural steroid injection. Complications include infection, steroidal side effects, inadvertent
dural puncture, epidural hematoma and nerve injury (Snarr, 2007). The most common technical
complication (as high as seven percent) of epidural steroid injections is inadvertent dural
puncture, which can lead to a post dural puncture headache with a distinguishing postural feature
of the headache (Snarr, 2007). The epidural hematoma is an extremely rare complication,
occurring approximately 1:200,000 neuraxial injections, which can lead to nerve ischemia
(Snarr, 2007).
The Mayo Clinic Proceedings published a study on epidural injections. According to their
research, epidural abscess is a rarely reported complication of epidural corticosteroid injection
for treatment of radicular back pain (Hooten, Kinney, & Huntoon, 2004). The incidence remains
undetermined but as the annual number of injections increase, specialists and physicians must
become aware of the potential infectious complications of this procedure. Of those cases that
developed a bacterial infection, diabetes mellitus is identified as the single most common risk
factor and S. aureus was the principal organism in 73% of the patients. Recommendations were
given to use chlorhexidine instead of povidone-iodine whenever a corticosteroid injection is to
be administered because it has been proven superior.
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Activity following cervical or lumbar puncture
Headache is a frequent problem following either a lumbar or cervical puncture. No evidence was
found that longer bed rest after cervical or lumbar puncture was more beneficial then immediate
mobilization in reducing the incidence of headache after diagnostic puncture, myelography, or
spinal anesthesia (Thoennissen et al., 2001).
DEFINITION OF TERMS
In this study, an interlaminar LESI was performed anywhere between levels L1-S1 under
fluoroscopic guidance and the number of injections in the last six months were recorded. Pain
was defined as any low back pain which may or may not radiate into the buttocks, legs, and feet,
potentially causing numbness and tingling and pain was measured by the Wong-Baker FACES
Pain Rating Scale. Back related functional disability level was measured by the ODI, which is a
nine-item scale ranging from zero to 100 percent with a high score indicating a high degree of
restriction. The ODI remains a valid and vigorous measurement of condition-specific disability
(Fairbank & Pynsent, 2000).
Expected adverse side effects of the lumbar epidural steroid injection were headache,
facial flushing, increased low back pain, trouble sleeping, or sweating. During the flat bed rest,
subjects laid flat on their stomach, side or back with one pillow under the head. Rest was defined
as avoiding vigorous activities that were known to cause low back irritation and pain for at least
24 hours following the injection.
METHODS
Study design
A quasi-experimental design was used with a control and experimental group completing a pre
and post surveys. The control group completed the current practice of the MDC which is 15
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minutes of flat rest on the fluoroscopy table followed by 45 minutes of flat rest in the nursing
area and were advised to rest for the remainder of the day. The experimental group completed 15
minutes of flat rest on the fluoroscopy table, 15 minutes of flat rest in the nursing area, and
resumed normal activity for the remainder of the day. Prior to the LESI, both groups were
informed that they may be kept longer if they experienced residual numbness from the Lidocaine
that affected their walking or balance. Both groups received aftercare instructions and were
required to have a driver.
Subjects were assigned to the control or experimental group based on a weekly rotation.
For example, weeks one, three, and five were in the control group and weeks two, four, and six
were in the experimental group. For the patients that had repeat LESIs, they remained in their
original group. For subjects who had a LESI at our facility within six months prior to the study
beginning, they were placed in the control group due to the radiologist wishing to maintain
consistency for the patient. If a patient refused to participate in the study, he or she followed the
current protocol of the MDC. When the primary radiologist or the primary investigator at the
MDC was gone, the study was suspended until he or she returned to maintain consistency and
eliminate any further variables.
Setting and participants
Subjects 18 years of age or older undergoing LESIs at the MDC in Minneapolis who were
capable of signing their own consent were recruited for this study. Subjects were not offered
inducements for participation. A professional medical interpreter was present if needed.
Subjects were enrolled in the study with no discrimination of age, race, gender, or
number of previous LESIs. The following demographic data was compiled for research purposes
with attention to HIPPA and privacy regulations: subject’s gender, age, date of injection, date of
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survey completion, and the number of LESIs they have had within the last year. Each subject
was assigned a research number in order to track their response and ensure confidentiality.
Confidentiality was maintained by tracking the subjects using their assigned research study
number only and no data was collected that would personally identify the subject. This was
clearly explained to the subject and they were encouraged to contact their ordering physician
directly to discuss the results of the LESI and any future treatment options or concerns.
Intervention
First, standard procedure for the clinic was followed. This included having the subject change,
obtaining a blood pressure, heart rate, and a history of their symptoms. The blood pressure and
heart rate data along with the history of their symptoms was kept confidential in the medical
record and not included in the study data. Then the LESI procedure was explained, risks
described and consent for procedure was obtained.
Following that, all patients were informed a research study was being performed to
evaluate the relationship between rest and pain relief following a LESI. If interested, they would
complete bed rest in the clinic following their injection and fill out a survey while in the clinic
and another survey would be mailed two weeks after. Patients were not told if they were in the
control or experimental group. If the subject agreed, the study was explained further and the
consent form was read. All questions were answered that the subject had and consent was
obtained.
After consent was obtained, both groups were asked by the primary investigator, a
radiology nurse, to fill out the pre-injection survey to rate their pain level base and disability.
Due to the fact that the radiologist, nurse, and technologist were all aware of which group the
subject was in, the study was single blind.
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After the procedure was complete and the bed rest was done, each patient received
written aftercare instructions. The only difference in the written aftercare instructions received
were that the control group was told to “continue to rest for the remainder of the day” and the
experimental group was told to “resume normal activity.” The subjects were informed that they
would receive a survey two weeks post LESI by mail in a self-addressed, stamped envelope so
they could report their pain and disability level along with any side effects (Figure I). The survey
and cover letter were translated in Hmong, Somali, and Spanish by Garden & Associates, Inc,
Translators and Interpreters. A cover letter was also attached to the survey to briefly explain the
study again and what was needed from the subject. If the subject did not respond, one more
survey was mailed one week later. If the subject did not respond again, they were removed from
the study. Subjects were encouraged to call the radiology nurse anytime if they experienced
complications or had any questions.
Measures
The Wong-Baker FACES Pain Rating Scale was used for assessing pain level and the ODI was
used to assess disability level. The ODI has emerged as one of the most commonly
recommended condition specific outcome measures for spinal disorders (Fairbank & Pynsent,
2000). Version 2.0 of the ODI was used with section eight omitted due to the possibility that
subjects may feel a question on their sex life was inappropriate.
Data analysis
The t-test (two-tailed) was used to determine whether the two groups differed at baseline and
follow-up for numerical variables. The Chi-square test was used to determine differences
between the baseline groups for categorical variables (gender, previous LESI). Baseline and post
treatment results were compared using the paired sample t-test. Differences were considered
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significant if the P value was less than .05. All statistical analyses were performed using SPSS
15.0 (SPSS Inc, Chicago IL).
Ethical considerations
This study was approved by the Institutional Review Board of St. Catherine University. It was
also approved by the NNC in conjunction with Dr. Anthony Cook, radiologist, and the director
of the MDC. Written consent was obtained from the participants to participate in the study.
FINDINGS
Overall, 66% (73/110) of participants completed the initial survey and the two-week follow up
survey, 70% (42) in the control group and 62% (31) in the experimental group.
Demographic Characteristics
The study includes 38% male in the control group and 48% male for the experimental group. The
mean age was 50.9 in the control group and 52.2 in the experimental group. The days between
initial survey completion and follow up survey completion for the control group was 22.2 and the
experimental group was 23.6.
As for subjects who had previous LESIs within the last six months, the control group
mean was 42.8% and the experimental group was 9.7% (p = 0.003). The only significant
difference (p value < 0.05) found in the demographic characteristics was the mean value of
LESIs subjects in the control group had within the last six months versus the experimental group.
Over 30% more control group subjects had a LESI within the last six months compared to the
experimental group (Table I).
Primary outcomes
Both groups had significantly less pain at the two-week follow-up period as measured by the
FACES pain scale. There were no differences between the two group means at baseline or
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follow-up (Table II). At baseline, the control group had a mean FACES score of 6.4 and the
experimental group had a mean score of 6.7. At the two week follow up, the control groups mean
score was 4.0 and the experimental groups mean score was 3.7.
Both groups had significantly less disability at the two-week follow-up period as
measured by the ODI. There were no differences between the two group means at baseline or
follow-up (Table III). At baseline, the control group had a mean ODI score of 0.404 and the
experimental group had a mean ODI score of 0.366. At the two week follow up, the control
groups mean score was 0.232 and the experimental groups mean score was 0.305.
Secondary outcome
Side effects were measured at the two-week follow-up period only. Participants could select
multiple side effects including headache, facial flushing, increased lower back pain, trouble
sleeping, sweating or other. The number of side effects for the control group mean was 1.9 and
the experimental group mean was 1.68 and there was no differences between the two group
means at follow-up (Table IV). The number of times a subject reported a side effect was also
calculated in each group. The types of side effects reported in the control group were: headache
(15), facial flushing (17), increased low back pain (12), trouble sleeping (17), sweating (10),
other (8) and 8 subjects reported no side effects. The experimental group reported the following:
headache (9), facial flushing (10), increased low back pain (10), trouble sleeping (12), sweating
(8), other (3) and 11 subjects reported no side effects.
DISCUSSION
The purpose of this study was to evaluate if length of rest had an effect on a subject’s self-rated
pain relief and disabilities related to back pain following a LESI. The research questions were as
follows: 1. Is there a difference between a subjects self reported pain and ODI before and two

LESI Research Study

14

weeks post LESI after completing one hour of flat rest in the clinic (15 minutes on the
fluoroscopy table and 45 minutes in the nursing area) and resting for the remainder of the day
compared with completing 15 minutes of flat rest on the fluoroscopy table and 15 minutes of flat
rest in the nursing area and resuming activity as normal? 2. What side effects (headache, facial
flushing, increased low back pain, trouble sleeping, or sweating) were experienced by the subject
following the LESI?
The literature identified potential benefits and complications pertaining to LESIs along
with how bed rest and activity had an impact on patients following a lumbar or cervical puncture.
However, there was no literature found regarding the best aftercare practice for patients
following a LESI to achieve maximum results. Findings from this study will help inform a
community norm.
The results of this study indicate that pain, disability, and side effects are much the same
regardless of the amount of rest immediately following a LESI which was also the hypothesized
result. Both groups showed significant improvement in pain and disability at the two-week
follow-up period, which was expected.
The finding of a significant difference between the experimental and control groups in
terms of history of a previous LESI within the last six months was expected because if the
subject had a previous LESI specifically within the previous six months, they were placed in the
control group deliberately in order to follow MDCs current protocol and provide consistent care
for the subject. It was possible for a subject in the experimental group to have had a previous
injection because subjects were always placed in the same group if they had a repeat LESI within
the time frame of the study. Pertaining to the rest of the baseline demographics, there was no
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statistical difference found which was expected as well. Since the group selection was rotated on
a weekly basis, it was not expected to find any difference in the characteristics.
Subjects from both experimental and control groups experienced a significant amount of
pain relief which was expected because that is the intended purpose of the LESI procedure.
However, there was no statistical difference in pain relief found between the control and
experimental group. Specifically pertaining to the FACES pain scale, it was found that activity
following the LESI did not have an effect on pain relief.
Subjects from both experimental and control groups experienced a significant decrease
in disability, Between the control and experimental groups, there was no statistical difference
related to their ODI scores. In regards to the ODI, it was found that activity following the LESI
did not have an effect on the disability score by subjects.
There was no statistical difference in the number and type of side effects reported
between the two groups. Activity after the LESI procedure did not affect the number or type of
side effects reported by subjects.
Future practice implications
As a result of these findings, length of rest and activity following a LESI did not have an effect
on the subject’s self-rated pain relief and disabilities related to back pain. This research can be
used to influence the standard of care for patients receiving a LESI at the MDC and hopefully
across the radiology community. As a result, receiving a LESI could become more convenient
for patients.
Limitations
The study was limited to subjects from one privately owned neurological clinic in the Midwest.
In order to get a broader client base, the study could be repeated using several clinics at a variety
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of locations. The control group had significantly more LESIs in the previous year and as a result,
their prior knowledge or experience with LESIs could have affected their perception of
procedural pain. This study also had limited power and is at risk for type II error due to the small
sample size.
Another limitation was the 34% non-response rate. Since the surveys were sent out via
mail, in order for the subject to respond, he or she needed to fill out the survey and then send
back with the provided self-addressed, stamped envelope via mail. Participants may have chosen
not to respond for a number of reasons, one of which may have been the time needed to fill out
the survey.
Implications for nursing practice
This study will help influence and form a clinical norm for care after a LESI, provide patients
with evidence based care, and promote the profession of nursing at the MDC as one that has
patient-centered care at its focus which is followed through with by completing research. There
is also the potential to make receiving LESIs more convenient for patients, with less time in the
clinic and a quicker in clinic recovery time which could translate to less time off of work and less
inconvenience. The best interest of the patient is at hand with the end goal of creating a standard
of care that would be most beneficial to the patient. Implications for future research include
repeating the study with a larger sample size and possibly adding another follow up survey at a
month or longer to see what the long term relief of pain is for subjects. It would also be helpful
to make the follow-up survey more convenient for subject completion, possibly adding an online
completion option.
CONCLUSIONS
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As shown by the results, there was no difference in pain relief found using the FACES
pain scale and the ODI pertaining to bed rest and activity following a LESI. It was also found
that between the control and experimental subjects, there was no statistical difference in number
of side effects. In conclusion, subjects who completed one hour of flat rest and rested for the
remainder of the day following a LESI had no statistical difference in pain relief, disability score,
or side effects experienced as compared with subjects who completed 30 minutes of flat rest and
resumed normal activity. This study concludes that activity and flat rest do not have an impact on
the subject’s self-rated pain relief, disability score, or number of side effects at the two week
follow-up.
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Table I. Baseline demographic characteristics
Control (N=42)
Mean (SD) or %
Male
38%
Age
50.9 (14.0)
Days between pre and post
22.2 (11.9)
LESI within last six months
42.8%
*Significant difference between groups (P<.05)

Experimental (N=31)
Mean (SD) or %
48%
52.2 (12.7)
23.6 (11.7)
9.7%

P value
0.379
0.674
0.605
0.003*

Experimental (N=31)
Mean (SD)
6.7 (2.1)
3.7* (2.3)

P value
0.414
0.507

Experimental (N=31)
Mean (SD)
.366 (.158)
.305* (.190)

P value
0.311
0.663

Experimental (N=31)
Mean (SD) or %
1.68 (1.56)

P value
0.528

Table II. FACES pain scale score

Baseline
Follow-up 2 weeks

Control (N=42)
Mean (SD)
6.4 (1.9)
4.0* (2.1)

*Significant difference from baseline (P<.05)

Table III. Oswestry disability index score

Baseline
Follow-up 2 weeks

Control (N=42)
Mean (SD)
.404 (.156)
.232* (.174)

*Significant difference from baseline (P<.05)

Table IV. Number of side effects

Follow-up 2 weeks

Control (N=42)
Mean (SD) or %
1.90 (1.48)
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